C-reactive protein: A tool in the follow-up of nosocomial pneumonia

Journal of Infection

Volumn 61, Issue 3, 2010, Pages 205-211

  Moreno, Marcelo Spegiorin ^a   Nietmann, Henrique ^a   Matias, Celso Murilo ^a   Lobo, Suzana Margareth ^a  

^a HOSPITAL DE BASE   (Brazil)

Author keywords

C reactive protein; Inflammatory markers; Nosocomial pneumonia; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CALCULATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG RESPONSE; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CODING; PNEUMONIA; PRESCRIPTION; PROSPECTIVE STUDY; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 77955607604     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.06.005     Document Type: Article

References (32)

1. Official Statement of the American Thoracic Society and the Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171(4):388-416. 10.1164/rccm.200405-644ST.
2. Sociedade Brasileira de Pneumologia e Tisiologia Diretrizes brasileiras para tratamento das pneumonias adquiridas no hospital e das associadas à ventilação mecânica - 2007. J Bras Pneumol 2007, 33(Suppl. 1):S1-S30,. 10.1590/S1806-37132007000700001.
3. Alp E., Güven M., Yildiz O., Aygen B., Voss A., Doganay M. Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study. Ann Clin Microbiol Antimicrob 2004, 3:17,. 10.1186/1476-0711-3-17.
4. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995, 274(8):639-644.
5. Vincent J.L., Rello J., Marshall J., Silva E., Anzueto A., Martin C.D., et al. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302(21):2323-2329. 10.1001/jama.2009.1754.
6. Craven D.E. Epidemiology of ventilator-associated pneumonia. Chest 2000, 117(4 Suppl. 2):186S-187S,. 10.1378/chest.117.4_suppl_2.186S.
7. Kollef M.H. What is ventilator-associated pneumonia and why is it important?. Respir Care 2005, 50(6):714-721.
8. Pepys M.B., Baltz M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein. Adv Immunol 1983, 34:141-212.
9. Lobo S.M., Lobo F.R., Bota D.P., Mélot C., Vicent J.L. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123(6):2043-2049. 10.1378/chest.123.6.2043.
10. Lobo S.M., Lobo F.R. Markers and mediators of inflammatory response in infection and sepsis. RBTI 2007, 19(2):211-215. 10.1590/S0103-507X2007000200012.
11. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005, 11(2):101-108. 10.1111/j.1469-0691.2004.01044.x.
12. Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 2002, 28(3):235-243. 10.1007/s00134-002-1209-6.
13. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 2006, 10(2):R63. 10.1186/cc4892.
14. Kerttula Y., Leinonen M., Koskela M., Makela P.H. The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J Infect 1987, 14(1):21-30.
15. Hopstaken R.M., Muris J.W., Knottnerus J.A., Kester A.D., Rinkens P.E., Dinant G.J. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003, 53(490):358-364.
16. Reny J.L., Vuagnat A., Ract C., Benoit M.O., Safar M., Fagon J.Y. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002, 30(3):529-535.
17. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005, 25(5):804-812. 10.1183/09031936.05.00071704.
18. Seligman R., Meisner M., Lisboa T.C., Hertz F.T., Filippin T.B., Fachel J.M., et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006, 10(5):R125. 10.1186/cc5036.
19. Lisboa T., Seligman R., Diaz E., Rodriguez A., Teixeira P.J., Rello J. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008, 36(1):166-171. 10.1097/01.CCM.0000297886.32564.CF.
20. Coelho L., Póvoa P., Almeida E., Fernandes A., Mealha R., Moreira P., et al. Usefulness of C-reactive protein in monitoring severe community-acquired pneumonia clinical course. Crit Care 2007, 11(4):R92. 10.1186/cc6105.
21. Yentis S.M., Soni N., Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995, 21(7):602-605.
22. Bruns A.H., Oosterheert J.J., Hak E., Hoepelman A.I. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 2008, 32(3):726-732. 10.1183/09031936.00003608.
23. Ho K.M., Dobb G.J., Lee K.Y., Towler S.C., Webb S.A. C-reactive protein concentration as a predictor of intensive care unit readmission: a nested case-control study. J Crit Care 2006, 21(3):259-266. 10.1016/j.jcrc.2006.01.005.
24. Ho K.M., Lee K.Y., Dobb G.J., Webb S.A. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 2008, 34(3):481-487. 10.1007/s00134-007-0928-0.
25. Rea-Neto A., Youssef N.C., Tuche F., Brunkhorst F., Ranieri V.M., Reinhart K., et al. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 2008, 12(2):R56. 10.1186/cc6877.
26. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22(7):707-710. On behalf of the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine.
27. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829.
28. Calandra T., Cohen J. The International Sepsis Forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005, 33(7):1538-1548. 10.1097/01.CCM.0000168253.91200.83.
29. Luna C.M., Blanzaco D., Niederman M.S., Matarucco W., Baredes N.C., Desmery P., et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003, 31(3):676-682,.
30. Schmit X., Vincent J.L. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008, 36(3):213-219. 10.1007/s15010-007-7077-9.
31. Kollef M.H., Sherman G., Ward S., Fraser V.J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115(2):462-474. 10.1378/chest.115.2.462.
32. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118(1):146-155. 10.1378/chest.118.1.146.